{"url":"https://lda.senate.gov/api/v1/filings/616b6bbb-e72d-479a-862f-1c7b88bdb7e7/","filing_uuid":"616b6bbb-e72d-479a-862f-1c7b88bdb7e7","filing_type":"RR","filing_type_display":"Registration","filing_year":2010,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/616b6bbb-e72d-479a-862f-1c7b88bdb7e7/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Donna F. Mullins, Managing Partner","dt_posted":"2010-03-08T12:06:01.210000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"819 7TH STREET, NW","registrant_address_2":"SUITE 501","registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":50796,"url":"https://lda.senate.gov/api/v1/registrants/50796/","house_registrant_id":34724,"name":"WINNING STRATEGIES WASHINGTON","description":"Government relations firm","address_1":"409 7TH STREET, NW","address_2":"SUITE 450","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA LAY","contact_telephone":"+1 202-589-0800","dt_updated":"2026-07-30T12:37:38.028096-04:00"},"client":{"id":157049,"url":"https://lda.senate.gov/api/v1/clients/157049/","client_id":1005305,"name":"MEDA PHARMACEUTICALS","general_description":"Pharmaceutical company specializing in respiratory and allergy products","client_government_entity":false,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-02-02"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FDA Risk Evaluation and Mitigation Strategies","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":35503,"prefix":null,"prefix_display":null,"first_name":"ALEX","nickname":null,"middle_name":null,"last_name":"DELPIZZO","suffix":null,"suffix_display":null},"covered_position":"LD/LA, Rep. Ferguson ;  ; Transportation and Infrastructure Cmte","new":true},{"lobbyist":{"id":43397,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"A","last_name":"MEROLA","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS, Sen. Torricelli","new":true}],"government_entities":[]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"FDA Risk Evaluation and Mitigation Strategies","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":35503,"prefix":null,"prefix_display":null,"first_name":"ALEX","nickname":null,"middle_name":null,"last_name":"DELPIZZO","suffix":null,"suffix_display":null},"covered_position":"LD/LA, Rep. Ferguson ;  ; Transportation and Infrastructure Cmte","new":true},{"lobbyist":{"id":43397,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"A","last_name":"MEROLA","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS, Sen. Torricelli","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}